Literature DB >> 10418124

Heterocyclic NO prodrugs.

K Schönafinger1.   

Abstract

An overview of the different heterocyclic NO-releasing compounds is given. Mesoionic heterocycles like sydnone imines are one example. This class is discussed on the synthesis and the mechanism of NO formation from Molsidomine and its first metabolite SIN-1. Furthermore, 1,2,3,4 oxatriazolium olates and imidates are presented in an example of the synthesis of GEA-3175. Heterocyclic N-oxides are another group of compounds capable of NO release under certain conditions. This class is discussed in the example of furoxane carboxamides like CAS-1609, and some SAR-data show the great impact of intramolecular hydrogen bridges on their in vitro activity. Each class of compounds requires different cofactors for NO release: sydnone imines need oxidants like oxygen, furoxanes are converted to NO via reaction with thioles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418124     DOI: 10.1016/s0014-827x(99)00031-2

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  6 in total

Review 1.  Multiple Targeting Approaches on Histamine H3 Receptor Antagonists.

Authors:  Mohammad A Khanfar; Anna Affini; Kiril Lutsenko; Katarina Nikolic; Stefania Butini; Holger Stark
Journal:  Front Neurosci       Date:  2016-05-30       Impact factor: 4.677

2.  Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.

Authors:  Kerry L Homer; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Decomposition mechanism of 3-N-morpholinosydnonimine (SIN-1)--a density functional study on intrinsic structures and reactivities.

Authors:  Roy U Rojas Wahl
Journal:  J Mol Model       Date:  2004-03-02       Impact factor: 1.810

4.  Nitric oxide modulators: an emerging class of medicinal agents.

Authors:  S R Deshpande; K Satyanarayana; M N A Rao; K V Pai
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

Review 5.  Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies.

Authors:  Justin S Bice; Bethan R Jones; Georgia R Chamberlain; Gary F Baxter
Journal:  Basic Res Cardiol       Date:  2016-02-24       Impact factor: 17.165

6.  Examination of imprinting process with molsidomine as a template.

Authors:  Piotr Luliński; Dorota Maciejewska
Journal:  Molecules       Date:  2009-06-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.